Development and evaluation of anthrax vaccine powder formulations for nasal mucosal delivery.

被引：0
|
作者：
Jiang, G
Sullivan, V
Mikszta, J
Joshi, S
Middaugh, CR
Huang, J
Alarcon, J
Ferriter, M
Woodley, W
Ford, B
Mar, K
Roy, C
Ulrich, R
Harvey, N
机构：
[1] BD Technol, Dept Adv Drug Delivery, Res Triangle Pk, NC 27709 USA
[2] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 228卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
182-BIOL
引用
收藏
页码：U201 / U201
页数：1
相关论文
共 50 条
  • [21] IN-VIVO EVALUATION OF SPRAY FORMULATIONS OF HUMAN INSULIN FOR NASAL DELIVERY
    DONDETI, P
    ZIA, HS
    NEEDHAM, TE
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 122 (1-2) : 91 - 105
  • [22] Viability evaluation of freeze dried and suspension anthrax spore vaccine formulations stored at different temperatures
    Abayneh, T.
    Getachew, B.
    Gelaye, E.
    Traxler, R.
    Vieira, A. R.
    VACCINE, 2021, 39 (42) : 6245 - 6249
  • [23] In vivo systemic evaluation of nasal drug absorption from powder formulations in rats
    Tatsuta, Ryosuke
    Tanaka, Akiko
    Ogawara, Ken-ichi
    Higaki, Kazutaka
    Furubayashi, Tomoyuki
    Sakane, Toshiyasu
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2025, 207
  • [24] The use of simple dynamic mucosal models and confocal microscopy for the evaluation of lyophilised nasal formulations
    McInnes, Fiona
    Baillie, Alan J.
    Stevens, Howard N. E.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 (06) : 759 - 767
  • [25] In vitro and in vivo Evaluation of the Efficacy and Safety of Powder Hydroxypropylmethylcellulose as Nasal Mucosal Barrier
    Popov, Todor A.
    Emberlin, Jean
    Josling, Peter
    Seifalian, Alexander
    MEDICAL DEVICES-EVIDENCE AND RESEARCH, 2020, 13 : 107 - 113
  • [26] Puerarin dry powder inhaler formulations for pulmonary delivery: Development and characterization
    Rashid, Md Abdur
    Muneer, Saiqa
    Wang, Tony
    Alhamhoom, Yahya
    Rintoul, Llew
    Izake, Emad L.
    Islam, Nazrul
    PLOS ONE, 2021, 16 (04):
  • [27] Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli
    Sloat, Brian R.
    Cui, Zhengrong
    VACCINE, 2006, 24 (40-41) : 6405 - 6413
  • [28] Progress in the development of Lactococcus lactis as a recombinant mucosal vaccine delivery system
    Norton, PM
    LePage, RWF
    Wells, JM
    FOLIA MICROBIOLOGICA, 1995, 40 (03) : 225 - 230
  • [29] Advances in effective vaccine development against hepatitis B: focus on mucosal vaccine delivery strategies
    Paliwal, Rishi
    Paliwal, Shivani R.
    Vyas, Suresh P.
    THERAPEUTIC DELIVERY, 2010, 1 (03) : 397 - 410
  • [30] Development and In Vitro Evaluation of Thermorevesible Nasal Gel Formulations of Rizatriptan Benzoate
    Praveen, Chaudhari
    Amit, Ajab
    Prashant, Malpure
    Pramod, Kolsure
    Devidas, Sanap
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2009, 43 (01) : 55 - 62
12345